StockData
Pro Dex Inc logo

Pro Dex Inc (PDEX) stock

PDEXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 18/3012% below fair value
$61.93−2.55 (-3.95%)

Close on Nov 17, 2026Market cap $198.18MP/E 17.1Yield –

Pro Dex revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pro Dex's revenue for the twelve months ending Sep 30, 2026 was $79.58M, up 13.3% year over year. For fiscal 2026 it was $77.55M, up 16.5% from the year before. Over ten years it grew 15.0% a year on average. The highest annual figure on record is $77.55M in fiscal 2026.

Annual revenue

PeriodPeriod endValueChange
FY2026Jun 30, 2026$77.55M+16.5%
FY2025Jun 30, 2025$66.59M+23.7%
FY2024Jun 30, 2024$53.84M+16.8%
FY2023Jun 30, 2023$46.09M+9.6%
FY2022Jun 30, 2022$42.04M+10.5%
FY2021Jun 30, 2021$38.03M+9.2%
FY2020Jun 30, 2020$34.83M+28.2%
FY2019Jun 30, 2019$27.17M+21.0%
FY2018Jun 30, 2018$22.47M+2.4%
FY2017Jun 30, 2017$21.94M+14.4%
FY2016Jun 30, 2016$19.19M+43.4%
FY2015Jun 30, 2015$13.38M+23.8%
FY2014Jun 30, 2014$10.81M-11.7%
FY2013Jun 30, 2013$12.25M+82.5%
FY2012Jun 30, 2012$6.71M-72.1%
FY2011Jun 30, 2011$24.06M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Sep 30, 2026$20.56M+11.0%
Q4 FY2026CQ2 2026Jun 30, 2026$20.41M+16.6%
Q3 FY2026CQ1 2026Mar 31, 2026$19.95M+14.6%
Q2 FY2026CQ4 2025Dec 31, 2025$18.66M+11.1%
Q1 FY2026CQ3 2025Sep 30, 2025$18.53M+24.4%
Q4 FY2025CQ2 2025Jun 30, 2025$17.49M+16.4%
Q3 FY2025CQ1 2025Mar 31, 2025$17.41M+21.8%
Q2 FY2025CQ4 2024Dec 31, 2024$16.79M+33.4%
Q1 FY2025CQ3 2024Sep 30, 2024$14.89M+24.7%
Q4 FY2024CQ2 2024Jun 30, 2024$15.03M+41.2%
Q3 FY2024CQ1 2024Mar 31, 2024$14.29M+9.3%
Q2 FY2024CQ4 2023Dec 31, 2023$12.59M+11.6%
Q1 FY2024CQ3 2023Sep 30, 2023$11.94M+7.7%
Q4 FY2023CQ2 2023Jun 30, 2023$10.64M-15.7%
Q3 FY2023CQ1 2023Mar 31, 2023$13.08M+41.2%
Q2 FY2023CQ4 2022Dec 31, 2022$11.28M+10.9%
Q1 FY2023CQ3 2022Sep 30, 2022$11.09M+11.0%
Q4 FY2022CQ2 2022Jun 30, 2022$12.62M+33.7%
Q3 FY2022CQ1 2022Mar 31, 2022$9.27M-21.1%
Q2 FY2022CQ4 2021Dec 31, 2021$10.17M+23.1%
Q1 FY2022CQ3 2021Sep 30, 2021$9.99M+16.3%
Q4 FY2021CQ2 2021Jun 30, 2021$9.44M-15.2%
Q3 FY2021CQ1 2021Mar 31, 2021$11.74M+38.0%
Q2 FY2021CQ4 2020Dec 31, 2020$8.27M+3.8%
Q1 FY2021CQ3 2020Sep 30, 2020$8.59M+18.6%
Q4 FY2020CQ2 2020Jun 30, 2020$11.12M+58.8%
Q3 FY2020CQ1 2020Mar 31, 2020$8.51M+24.1%
Q2 FY2020CQ4 2019Dec 31, 2019$7.96M+24.4%
Q1 FY2020CQ3 2019Sep 30, 2019$7.24M+4.7%
Q4 FY2019CQ2 2019Jun 30, 2019$7.00M+12.1%
Q3 FY2019CQ1 2019Mar 31, 2019$6.85M+24.8%
Q2 FY2019CQ4 2018Dec 31, 2018$6.40M+15.1%
Q1 FY2019CQ3 2018Sep 30, 2018$6.92M+34.0%
Q4 FY2018CQ2 2018Jun 30, 2018$6.25M+11.6%
Q3 FY2018CQ1 2018Mar 31, 2018$5.49M-17.0%
Q2 FY2018CQ4 2017Dec 31, 2017$5.56M+20.9%
Q1 FY2018CQ3 2017Sep 30, 2017$5.16M–
Q4 FY2017CQ2 2017Jun 30, 2017$5.60M–
Q3 FY2017CQ1 2017Mar 31, 2017$6.62M–
Q2 FY2017CQ4 2016Dec 31, 2016$4.60M–

More Pro Dex figures

See a number that looks wrong?